doctor reddy's lab-adr (RDY:New York)
Transactions by DOCTOR REDDY'S LAB-ADR (RDY) in the last 6 months
Dr. Reddy's Laboratories Ltd. (BSE:500124) entered into a definitive agreement to acquire Portfolio of Established Product Business from UCB India Private Limited for INR 8 billion on April 1, 2015. Transaction includes 350 employees of business. The portfolio reported revenues of INR 1.5 billion for the year ended December 31, 2014. The transaction is expected to be completed in the first quarter of the financial year 2015-16.
Dr. Reddy's Laboratories Ltd. (BSE:500124) acquired the assets of Cherokee Pharma, LLC for $4.7 million during the quarter ended September 30, 2014.
|Cadila Healthcare Ltd||1,662 INR||-40.10|
|Cipla Ltd/India||631.65 INR||+3.20|
|Croda International PLC||2,945 GBp||-26.00|
|Nipro Corp||¥1,158 JPY||-6.00|
|Symrise AG||€56.88 EUR||-0.84|
|View Industry Companies|